These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36677600)

  • 1. Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking.
    Krstulović L; Leventić M; Rastija V; Starčević K; Jirouš M; Janić I; Karnaš M; Lasić K; Bajić M; Glavaš-Obrovac L
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 1,2,3-Triazole-Containing Quinoline-Benzimidazole Hybrids: Synthesis, Antiproliferative Activity, In Silico ADME Predictions, and Docking.
    Krstulović L; Mišković Špoljarić K; Rastija V; Filipović N; Bajić M; Glavaš-Obrovac L
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Anti-tumor Activity of Novel 2-Aryl Benzimidazole Compounds.
    Xiaohelaiti H; Wu W; Gao Y; Li S; Ma C
    Anticancer Agents Med Chem; 2023; 23(14):1644-1651. PubMed ID: 37055901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors.
    Acar Çevik U; Celik I; Işık A; Ahmad I; Patel H; Özkay Y; Kaplancıklı ZA
    J Biomol Struct Dyn; 2023 Mar; 41(5):1944-1958. PubMed ID: 35037830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, Antitumor, and Antiplasmodial Evaluation of New 7-Chloroquinoline-Benzimidazole Hybrids.
    Krstulović L; Rastija V; Pessanha de Carvalho L; Held J; Rajić Z; Živković Z; Bajić M; Glavaš-Obrovac L
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38998949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
    Sever B; Altıntop MD; Çiftçi GA; Özdemir A
    Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
    Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
    Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Antiproliferative Evaluation and QSAR Analysis of Novel Halogen- and Amidino-Substituted Benzothiazoles and Benzimidazoles.
    Rep Kaulić V; Racané L; Leventić M; Šubarić D; Rastija V; Glavaš-Obrovac L; Raić-Malić S
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New benzimidazole based hybrids: Synthesis, molecular modeling study and anticancer evaluation as TopoII inhibitors.
    Nawareg NA; Mostafa AS; El-Messery SM; Nasr MNA
    Bioorg Chem; 2022 Oct; 127():106038. PubMed ID: 35870412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Benzimidazoles Targeting Breast Cancer: Synthesis, Pin1 Inhibition, 2D NMR Binding, and Computational Studies.
    Nashaat S; Henen MA; El-Messery SM; Eisa H
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel benzimidazole-triazole hybrids as apoptosis inducing agents in lung cancer: Design, synthesis,
    Sridhar Goud N; Pooladanda V; Muni Chandra K; Lakshmi Soukya PS; Alvala R; Kumar P; Nagaraj C; Dawn Bharath R; Qureshi IA; Godugu C; Alvala M
    Bioorg Chem; 2020 Sep; 102():104125. PubMed ID: 32738568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors.
    Akhtar MJ; Khan AA; Ali Z; Dewangan RP; Rafi M; Hassan MQ; Akhtar MS; Siddiqui AA; Partap S; Pasha S; Yar MS
    Bioorg Chem; 2018 Aug; 78():158-169. PubMed ID: 29571113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
    Kadela-Tomanek M; Bębenek E; Chrobak E; Marciniec K; Latocha M; Kuśmierz D; Jastrzębska M; Boryczka S
    Eur J Med Chem; 2019 Sep; 177():302-315. PubMed ID: 31158746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of imidazo[1,5-a]pyridine-benzimidazole hybrids as inhibitors of both tubulin polymerization and PI3K/Akt pathway.
    Kamal A; Rao AV; Nayak VL; Reddy NV; Swapna K; Ramakrishna G; Alvala M
    Org Biomol Chem; 2014 Dec; 12(48):9864-80. PubMed ID: 25354805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors.
    Ali IH; Abdel-Mohsen HT; Mounier MM; Abo-Elfadl MT; El Kerdawy AM; Ghannam IAY
    Bioorg Chem; 2022 Sep; 126():105883. PubMed ID: 35636123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies.
    Sana S; Reddy VG; Srinivasa Reddy T; Tokala R; Kumar R; Bhargava SK; Shankaraiah N
    Bioorg Chem; 2021 May; 110():104765. PubMed ID: 33677248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell Cycle Arrest and Apoptosis-Inducing Ability of Benzimidazole Derivatives: Design, Synthesis, Docking, and Biological Evaluation.
    Nazreen S; Almalki ASA; Elbehairi SEI; Shati AA; Alfaifi MY; Elhenawy AA; Alsenani NI; Alfarsi A; Alhadhrami A; Alqurashi EA; Alam MM
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
    Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
    Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, Docking Study, and Antiproliferative Evaluation of Novel Schiff Base-Benzimidazole Hybrids with VEGFR-2 Inhibitory Activity.
    Abd El-Lateef HM; Elbastawesy MAI; Abdelghani Ibrahim TM; Khalaf MM; Gouda M; Wahba MGF; Zaki I; Morcoss MM
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.